Overview of Raymond James' Rating#
Raymond James has begun coverage on WisdomTree Investments, assigning it an 'Outperform' rating. The firm has set a price target of $20.00 for the stock, which is currently trading at $17.48. Over the past year, WisdomTree's stock has surged by 129%, although some analyses suggest it may be overvalued compared to its fair market value.
Company Growth and Financial Performance#
WisdomTree specializes in exchange-traded products and has seen its assets under management grow to $150.6 billion as of the first quarter of 2026. This growth has been impressive, with a compound annual growth rate in the high teens over the last four years. Raymond James anticipates that WisdomTree will experience mid-teens growth in earnings per share, driven by expanding profit margins on new business ventures.
Strategic Initiatives and Acquisitions#
The firm points to WisdomTree's ongoing product development as a key factor for continued growth in assets under management. The company plans to launch new private market exchange-traded funds and alternative strategy ETFs in 2026, which are expected to increase fees and profit margins. Recent acquisitions, including Ceres Partners and Atlantic House, have also provided WisdomTree access to niche markets with higher fees.
Recent Financial Results#
In its latest financial report for the fourth quarter of 2025, WisdomTree exceeded analysts' expectations, posting earnings per share of $0.29 against a forecast of $0.24. Revenues reached $147.4 million, surpassing the anticipated $142.69 million. Additionally, WisdomTree announced a significant acquisition of Atlantic House Holdings Limited for approximately $200 million, which will enhance its investment strategy capabilities. To finance this acquisition, the company plans to issue $525 million in convertible senior notes, with part of the proceeds also aimed at repaying existing debt.